Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanine nucleotide-binding protein G(t) subunit alpha-3 (GNAT3) is the alpha subunit of a heterotrimeric G protein primarily involved in the transduction of bitter, sweet, and umami taste signals from taste receptor cells. It transduces signals from specific cell-surface taste receptors (TAS1R and TAS2R families), activating intracellular effectors such as phosphodiesterase, reducing cAMP and cGMP, and ultimately increasing intracellular calcium to lead to neurotransmitter release. GNAT3 is expressed in oral epithelium and certain gut tissues, where it also functions as a sensor for luminal sugars, modulating glucose transporter expression and hormone secretion, linking taste perception to metabolic regulation and nutrient absorption. Genetic variants in GNAT3 have been associated with susceptibility to metabolic syndrome and dental caries[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine nucleotide-binding protein G(t) subunit alpha-3 (GNAT3).